SPRO
$2.58
Spero Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on identifying and developing novel treatments for multi-drug resistant (MDR) bacterial infections and rare diseases in the United States.
Intraday
Recent News
Airgain And 2 Other Promising Penny Stocks
As February begins, the U.S. stock market has shown a robust start with major indexes like the Dow Jones Industrial Average and S&P 500 ending sharply higher. For those looking to invest in smaller or newer companies, penny stocks—despite their name's vintage feel—can still offer surprising value. This article explores three penny stocks that demonstrate financial strength and potential for long-term growth, offering an intriguing opportunity for investors seeking to diversify their...
3 Promising Penny Stocks With Market Caps Up To $300M
Major stock indexes in the United States have recently shown mixed performance, with the Dow Jones Industrial Average and S&P 500 setting fresh all-time highs. Amid these fluctuating market conditions, investors are increasingly exploring diverse opportunities to maximize potential returns. Penny stocks, though a term from earlier market days, continue to represent intriguing investment prospects by offering access to smaller or newer companies at lower price points. By identifying those with...
Is Spero Therapeutics (NASDAQ:SPRO) In A Good Position To Deliver On Growth Plans?
Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...
3 Promising Penny Stocks With Market Caps Over $20M
Major stock indexes in the United States have recently experienced a pullback, with technology shares leading the decline. Despite these broader market challenges, certain investment opportunities remain attractive, particularly within the realm of penny stocks. While often associated with smaller or newer companies, penny stocks can offer significant growth potential when backed by strong financials. In this article, we will explore several such stocks that stand out for their financial...
Best Momentum Stock to Buy for October 10th
SPRO made it to the Zacks Rank #1 (Strong Buy) momentum stock list on October 10, 2025.